Artiva Biotherapeutics, Inc. (ARTV) vs Enanta Pharmaceuticals, Inc. (ENTA)
A side-by-side comparison of Artiva Biotherapeutics, Inc. and Enanta Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ARTV
Artiva Biotherapeutics, Inc.
$7.27HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
ENTA
Enanta Pharmaceuticals, Inc.
$12.17HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ARTV vs ENTA
growth of $100 · dividends reinvested · last 2yARTV -40.6% (-22.9%/yr)ENTA -22.0% (-11.7%/yr)ENTA compounded faster over this window
ARTV ENTA
ARTV vs ENTA: by the numbers
- •ARTV is the larger company ($355M vs $354M market cap).
- •Both run net losses; ARTV's is the smaller (0.00% vs -96.89% net margin).
Metrics side by side
Valuation
| Metric | ARTV | ENTA |
|---|---|---|
| P/S ratio | N/A | 5.42 |
| P/B ratio | 1.02 | 3.50 |
Profitability
| Metric | ARTV | ENTA |
|---|---|---|
| Gross margin | 0.00% | 98.15% |
| Operating margin | 0.00% | -130.65% |
| Net margin | 0.00% | -96.89% |
| ROE | -26.14% | -62.56% |
| ROIC | -27.16% | -24.20% |
Growth (annualized)
| Metric | ARTV | ENTA |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -7.65% |
| Total return CAGR (5Y) | N/A | -26.94% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.